Solani Therapeutics Ltd is a Finland-based startup that focuses on developing innovative solutions for animal therapeutics. The company's approach involves combining existing active pharmaceutical ingredients with novel formulations and delivery methods. Their market-oriented strategy includes building project-specific networks with leading veterinary and technology expertise to identify commercially attractive, low-risk product ideas for the treatment of companion animals, both in veterinary clinics and at home. The company commenced its first project, which entered the preclinical phase in August 2014. Solani Therapeutics Ltd recently secured Seed Round investment on 01 January 2022 from Korpun Siemen, highlighting the significant interest and support from the investment community. This investment is expected to further drive the development and expansion of Solani's innovative animal therapeutics solutions.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | Unknown | 1 |
|
01 Jan 2022 |
No recent news or press coverage available for Solani Therapeutics Ltd.
We care about your data, and we'd love to use cookies make your experience better.